Literature DB >> 143229

Corticosteroid glaucoma.

J François.   

Abstract

Chronic as well as acute glaucoma can be induced by corticosteroids. The hypertensive response to the topical corticosteroid test is not genetically determined. The pathogenesis of the corticosteroid glaucoma can be explained by clones of goniocytes, which contain mucopolysaccharides sensitive to hyaluronidase. When these mucopolysaccharides are polymerized, they retain water and when they are depolymerized, they loose water. As the corticosteroid strengthen the lysosomal membranes, the retained catabolising enzymes prevent the catabolism of the mucopolysaccharides, which tend to accumulate in a more polymerized and more hydrophilic form.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 143229

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN: 0003-4886


  20 in total

Review 1.  Locally administered ocular corticosteroids: benefits and risks.

Authors:  Charles N J McGhee; Simon Dean; Helen Danesh-Meyer
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Delayed therapeutic success with endoscopic cyclophoto-coagulation in treating refractory post-penetrating keratoplasty glaucoma.

Authors:  D A Hollander; S C Lin
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

3.  Increased intraocular pressure during treatment for chronic uveitis.

Authors:  D BenEzra; Y S Wysenbeek; E Cohen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-04       Impact factor: 3.117

4.  Corticosteroid-induced ocular hypertension. I. Prevalence in closed-angle glaucoma.

Authors:  A O Akingbehin
Journal:  Br J Ophthalmol       Date:  1982-08       Impact factor: 4.638

5.  Intraocular pressure response to corticosteroids in children.

Authors:  B Z Biedner; R David; A Grudsky; U Sachs
Journal:  Br J Ophthalmol       Date:  1980-06       Impact factor: 4.638

Review 6.  Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine.

Authors:  M Elizabeth Fini; Stephen G Schwartz; Xiaoyi Gao; Shinwu Jeong; Nitin Patel; Tatsuo Itakura; Marianne O Price; Francis W Price; Rohit Varma; W Daniel Stamer
Journal:  Prog Retin Eye Res       Date:  2016-09-22       Impact factor: 21.198

7.  Glaucoma in patients with uveitis.

Authors:  W C Panek; G N Holland; D A Lee; R E Christensen
Journal:  Br J Ophthalmol       Date:  1990-04       Impact factor: 4.638

8.  Corticosteroid-induced ocular hypertension. II. An acquired form.

Authors:  A O Akingbehin
Journal:  Br J Ophthalmol       Date:  1982-08       Impact factor: 4.638

Review 9.  Managing early presentation of rheumatoid arthritis. Systematic overview.

Authors:  R Glazier
Journal:  Can Fam Physician       Date:  1996-05       Impact factor: 3.275

Review 10.  A review of systemic medications that may modulate the risk of glaucoma.

Authors:  Annie Wu; Anthony P Khawaja; Louis R Pasquale; Joshua D Stein
Journal:  Eye (Lond)       Date:  2019-10-08       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.